Abstract
No public abstract is available from the verified source records.
Jin Mou, Suchit Shashikumar, Aman Kumar Shah, Amit Chaudhary, Prity Lata Chakraborty, Angelina Yang, Angira Shah
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2021
Unresolved referenced work
Kept as external metadata until matched
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f · 1999
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
10.1016/s2214-109x(19)30482-6 · 2020
Unresolved referenced work
2020
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
10.1016/s0140-6736(13)62218-7 · 2014
Unresolved referenced work
2024
Unresolved referenced work
2023
Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
10.1186/s13027-020-00328-1 · 2020
Evaluation of an isothermal amplification HPV assay on self-collected vaginal samples as compared to clinician-collected cervical samples
datacite
Confidence 0%
10.3390/diagnostics13213297 · 2023
Unresolved referenced work
2021
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study
10.3802/jgo.2024.35.e6 · 2024
Unresolved referenced work
2024
Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana
10.3332/ecancer.2021.1248 · 2021
Improved cervical screening using HPV type restriction and cycle threshold limit setting with the AmpFire assay: a prospective screening cohort of women with and without HIV in Botswana
10.1002/ijgo.70074 · 2025
Feasibility and acceptability of an HPV self-testing strategy: lessons from a research context to assess for ability to implement into primary care at a national level in Botswana
10.3389/fgwh.2023.1300788 · 2024
SANRA, a scale for the quality assessment of narrative review articles
10.1186/s41073-019-0064-8 · 2019
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
10.7326/m18-0850 · 2018
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
2000
AmpFire HPV and ScreenFire RS HPV validation trial
10.1093/ajcp/aqad181 · 2024
Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
10.1186/s13027-023-00504-z · 2023
Design of the HPV-Automated Visual Evaluation (PAVE) study: validating a novel cervical screening strategy
2024
Analytical performance of the ScreenFire HPV RS Zebra BioDome assay on four different qPCR platforms
10.1186/s13027-025-00651-5 · 2025
Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi
10.1186/s13027-024-00585-4 · 2024
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: a cross-sectional study
10.1002/ijc.34698 · 2024
SCALE: single visit clinical validation of ScreenFire, a low-cost HPV test - efficacy and cost effectiveness
2026
One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique
10.1038/s41467-025-62454-x · 2025
Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review
10.1186/s12905-022-02043-y · 2022
Public health concern-driven insights and response of low- and middle-income nations to the World Health Organization call for cervical cancer risk eradication
2024
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
10.1136/bmjgh-2018-001351 · 2019
Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: experience from Battor, Ghana
10.1371/journal.pgph.0001639 · 2023
Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferences
2025
Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019
10.1200/go.23.00385 · 2024
Evaluation of liquid versus dry specimen transport with a newly validated isothermal amplification high-risk HPV assay
10.1097/lgt.0000000000000546 · 2020
Advances in technologies for cervical cancer detection in low-resource settings
10.1080/14737159.2019.1648213 · 2019
Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening
10.3390/v16121852 · 2024
Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries
10.1136/bmjopen-2022-065074 · 2023
A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing
10.1186/s13027-020-00329-0 · 2020
Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen)
10.1007/s11033-023-08939-8 · 2024
Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda
10.4102/ajlm.v11i1.1827 · 2022
Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study
10.1186/s12913-025-13467-1 · doi-reference
Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: a systematic review and meta-analysis
10.1016/j.ygyno.2022.06.012 · doi-reference
Estimates of the global burden of cervical cancer associated with HIV
10.1016/s2214-109x(20)30459-9 · doi-reference
A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities
10.3389/fpubh.2021.670032 · doi-reference
Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
10.1136/bmj.k4823 · doi-reference
Triage of HPV positivity in a high HIV prevalence setting: a prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana
10.1002/ijgo.15225 · doi-reference
An isothermal, multiplex amplification assay for detection and genotyping of human papillomaviruses in formalin-fixed, paraffin-embedded tissues
10.1016/j.jmoldx.2019.12.004 · doi-reference